121 related articles for article (PubMed ID: 9190895)
1. Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis.
Cheng JQ; Altomare DA; Klein MA; Lee WC; Kruh GD; Lissy NA; Testa JR
Oncogene; 1997 Jun; 14(23):2793-801. PubMed ID: 9190895
[TBL] [Abstract][Full Text] [Related]
2. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas.
Ruggeri BA; Huang L; Wood M; Cheng JQ; Testa JR
Mol Carcinog; 1998 Feb; 21(2):81-6. PubMed ID: 9496907
[TBL] [Abstract][Full Text] [Related]
3. Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin.
Altomare DA; Lyons GE; Mitsuuchi Y; Cheng JQ; Testa JR
Oncogene; 1998 May; 16(18):2407-11. PubMed ID: 9620559
[TBL] [Abstract][Full Text] [Related]
4. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.
Altomare DA; Guo K; Cheng JQ; Sonoda G; Walsh K; Testa JR
Oncogene; 1995 Sep; 11(6):1055-60. PubMed ID: 7566964
[TBL] [Abstract][Full Text] [Related]
5. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
6. Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2.
Mitsuuchi Y; Johnson SW; Sonoda G; Tanno S; Golemis EA; Testa JR
Oncogene; 1999 Sep; 18(35):4891-8. PubMed ID: 10490823
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic transformation induced by membrane-targeted Akt2 and Akt3.
Mende I; Malstrom S; Tsichlis PN; Vogt PK; Aoki M
Oncogene; 2001 Jul; 20(32):4419-23. PubMed ID: 11466625
[TBL] [Abstract][Full Text] [Related]
8. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
Bellacosa A; de Feo D; Godwin AK; Bell DW; Cheng JQ; Altomare DA; Wan M; Dubeau L; Scambia G; Masciullo V; Ferrandina G; Benedetti Panici P; Mancuso S; Neri G; Testa JR
Int J Cancer; 1995 Aug; 64(4):280-5. PubMed ID: 7657393
[TBL] [Abstract][Full Text] [Related]
9. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells.
Liu AX; Testa JR; Hamilton TC; Jove R; Nicosia SV; Cheng JQ
Cancer Res; 1998 Jul; 58(14):2973-7. PubMed ID: 9679957
[TBL] [Abstract][Full Text] [Related]
10. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
11. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.
Cheng JQ; Ruggeri B; Klein WM; Sonoda G; Altomare DA; Watson DK; Testa JR
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3636-41. PubMed ID: 8622988
[TBL] [Abstract][Full Text] [Related]
12. Novel human oncogene lbc detected by transfection with distinct homology regions to signal transduction products.
Toksoz D; Williams DA
Oncogene; 1994 Feb; 9(2):621-8. PubMed ID: 8290273
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth.
Liu X; Powlas J; Shi Y; Oleksijew AX; Shoemaker AR; De Jong R; Oltersdorf T; Giranda VL; Luo Y
Anticancer Res; 2004; 24(5A):2697-704. PubMed ID: 15517874
[TBL] [Abstract][Full Text] [Related]
14. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.
Cheng JQ; Godwin AK; Bellacosa A; Taguchi T; Franke TF; Hamilton TC; Tsichlis PN; Testa JR
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9267-71. PubMed ID: 1409633
[TBL] [Abstract][Full Text] [Related]
15. A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice.
Liu L; Yu XZ; Li TS; Song LX; Chen PL; Suo TL; Li YH; Wang SD; Chen Y; Ren YM; Zhang SP; Chang ZJ; Fu XY
Cancer Res; 2004 May; 64(10):3491-9. PubMed ID: 15150103
[TBL] [Abstract][Full Text] [Related]
16. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers.
Bischoff JR; Anderson L; Zhu Y; Mossie K; Ng L; Souza B; Schryver B; Flanagan P; Clairvoyant F; Ginther C; Chan CS; Novotny M; Slamon DJ; Plowman GD
EMBO J; 1998 Jun; 17(11):3052-65. PubMed ID: 9606188
[TBL] [Abstract][Full Text] [Related]
17. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis.
Kim YC; Song KS; Yoon G; Nam MJ; Ryu WS
Oncogene; 2001 Jan; 20(1):16-23. PubMed ID: 11244501
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells.
Arboleda MJ; Lyons JF; Kabbinavar FF; Bray MR; Snow BE; Ayala R; Danino M; Karlan BY; Slamon DJ
Cancer Res; 2003 Jan; 63(1):196-206. PubMed ID: 12517798
[TBL] [Abstract][Full Text] [Related]
20. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
